North America Retinal Biologics Market

North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

Report Id: KBV-16640 Publication Date: July-2023 Number of Pages: 111
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
TABLE 1 North America Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 2 North America Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 3 North America Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 4 North America Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 5 North America Macular Degeneration Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Macular Degeneration Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Diabetic Retinopathy Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Diabetic Retinopathy Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 12 North America Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 13 North America VEGF-A Antagonist Market by Country, 2019 - 2022, USD Million
TABLE 14 North America VEGF-A Antagonist Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 North America Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 19 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Retinal Biologics Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Retinal Biologics Market by Country, 2023 - 2030, USD Million
TABLE 27 US Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 28 US Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 29 US Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 30 US Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 31 US Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 32 US Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 33 US Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 US Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 Canada Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 36 Canada Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 37 Canada Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 38 Canada Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 39 Canada Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 40 Canada Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 41 Canada Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Canada Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 Mexico Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 44 Mexico Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 45 Mexico Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 46 Mexico Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 47 Mexico Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 48 Mexico Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 49 Mexico Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Mexico Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 Rest of North America Retinal Biologics Market, 2019 - 2022, USD Million
TABLE 52 Rest of North America Retinal Biologics Market, 2023 - 2030, USD Million
TABLE 53 Rest of North America Retinal Biologics Market by Indication, 2019 - 2022, USD Million
TABLE 54 Rest of North America Retinal Biologics Market by Indication, 2023 - 2030, USD Million
TABLE 55 Rest of North America Retinal Biologics Market by Drug Class, 2019 - 2022, USD Million
TABLE 56 Rest of North America Retinal Biologics Market by Drug Class, 2023 - 2030, USD Million
TABLE 57 Rest of North America Retinal Biologics Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Rest of North America Retinal Biologics Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 Key Information – Novartis AG
TABLE 60 Key Information – Amgen, Inc.
TABLE 61 Key information – AbbVie, Inc.
TABLE 62 Key Information – Bayer AG
TABLE 63 Key Information – Regeneron Pharmaceuticals, Inc.
TABLE 64 Key Information – Santen Pharmaceutical Co., Ltd.
TABLE 65 key information – Bausch Health Companies, Inc.
TABLE 66 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 67 Key Information – MeiraGTx Holdings plc
TABLE 68 Key Information – Oxurion NV

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Retinal Biologics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Retinal Biologics Market
FIG 4 Porter’s Five Forces Analysis - Retinal Biologics Market
FIG 5 North America Retinal Biologics Market share by Indication, 2022
FIG 6 North America Retinal Biologics Market share by Indication, 2030
FIG 7 North America Retinal Biologics Market by Indication, 2019 - 2030, USD Million
FIG 8 North America Retinal Biologics Market share by Drug Class, 2022
FIG 9 North America Retinal Biologics Market share by Drug Class, 2030
FIG 10 North America Retinal Biologics Market by Drug Class, 2019 - 2030, USD Million
FIG 11 North America Retinal Biologics Market share by Distribution Channel, 2022
FIG 12 North America Retinal Biologics Market share by Distribution Channel, 2030
FIG 13 North America Retinal Biologics Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 North America Retinal Biologics Market share by Country, 2022
FIG 15 North America Retinal Biologics Market share by Country, 2030
FIG 16 North America Retinal Biologics Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Novartis AG
FIG 18 Swot Analysis: Amgen, Inc.
FIG 19 Swot Analysis: AbbVie, Inc.
FIG 20 Swot Analysis: Bayer AG
FIG 21 Swot Analysis: Regeneron Pharmaceuticals, Inc.
FIG 22 Swot Analysis: Santen Pharmaceutical Co., Ltd.
FIG 23 Recent strategies and developments: Bausch Health Companies, Inc.
FIG 24 Swot Analysis: Bausch Health Companies, Inc.
FIG 25 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 26 Swot Analysis: MeiraGTx Holdings plc
FIG 27 Swot Analysis: Oxurion NV
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo